Chief Financial Officer
Mr. Domescik has more than 15 years of experience in financial and executive management at emerging growth, life science companies and in investment banking. Prior to joining Javara, Drew spent over five years with Pharmaceutical Product Development, Inc. (PPD), a leading global Contract Research Organization (CRO), where he led cross-functional teams to execute company wide initiatives, acquisitions and integrations, and business unit strategy development and implementation. Previously, Drew served as the Finance Director of Validant, a privately held life science quality, compliance and regulatory consulting company. Prior to joining Validant, Drew was an investment banker for Navigant Capital Advisors, LLC where he executed numerous corporate financings, operational rehabilitations, capital restructurings, and mergers and acquisition transactions.
Drew received his Bachelor of Arts from Vanderbilt University, a Master of Science in biotechnology from Johns Hopkins University and his MBA from Emory University’s Goizeuta Business School.